Avedro is a startup based in the United States. Brouky records 1 investor associated with the company.
Avedro is a commercial-stage ophthalmic medical technology company that develops devices and drug formulations for corneal cross-linking to treat corneal ectatic disorders and improve vision, reducing reliance on eyeglasses or contact lenses.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.